Navigation Links
Roche clinical trial registry and results database launched

Within only three months after deciding to create an electronic database, Roche is launching a public clinical trial registry and results database using an independent host, CenterWatch. On www.roche-trials.com information on Roche’s clinical trials can be accessed by anyone, anywhere, with no password restrictions. This site is designed to give patients and healthcare providers ready access to information they need, in terms they can understand.

Ed Holdener, Head of Global Pharma Development at Roche, said: “We are proud to go live with our publicly accessible protocol registry and clinical trial results database today. Transparency has always been and continues to be a priority for us. In January, we announced our plans to have an independent host for the database and since then, we selected CenterWatch, a company with a wealth of experience in the area of data management and the publication of clinical trial information. So for the first time ever, there is now a global and publicly accessible database, containing comprehensive information about Roche’s clinical trials?

Roche expects that the huge task of publishing data from more than 30 medicines, on a product by product level from a large number of global and local trials, will take approximately a year. Roche will also continue to contribute information to established databases (i.e. www.clinicaltrials.gov)

Information that can be found in the electronic database
Starting with Fuzeon and Bondronat, clinical trial information will be added in a staged approach on the databases and will ultimately include protocol information and results from all Phase II to Phase IV clinical trials completed after 1 October, 2004. In addition, data from all Phase II to Phase IV clinical trials for medicines first marketed after 1 October, 2002 will be included retrospectively. The clinical trial registry and results database will also include interventional clinical studies from Roche Diagnostics.<
'"/>

Source:Roche


Page: 1 2 3

Related biology news :

1. Rochester scientists develop fast-working biosensor
2. NIAID begins clinical trial of West Nile virus vaccine
3. Compound might defeat African sleeping sickness, clinical trial beginning this month
4. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
5. Dalai Lama, top scientists to discuss science & clinical applications of meditation
6. Stem cells electric abilities might help their safe clinical use
7. New malaria vaccine shows promise in early clinical trial
8. Preclinical study of a new brain tumor therapy
9. Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging
10. Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial
11. NIH announces phase III clinical trial of creatine for Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Roche clinical trial registry and results database launched

(Date:7/30/2014)... in Lewis Carroll,s Through the Looking Glass, collaborators ... of Singapore improved a 35-year-old ecology model to ... millions of years. , The new model, called ... "Red Queen Effect," an evolutionary hypothesis introduced by ... that organisms must constantly increase their fitness (or ...
(Date:7/30/2014)... Society (ACS) announced today that David L. Kaplan, Ph.D., ... Science & Engineering as editor-in-chief. With the first ... journal will feature high-quality research in the rapidly burgeoning ... derived materials that interact with living or biological systems. ... the tremendous growth in the field of biomaterials over ...
(Date:7/30/2014)... shortest distance between two points is a straight line, ... been taking the familiar axiom to heart. , ... be intense, with each racing for the chance to ... sperm form cooperative groups that allow them to take ... new study, conducted by Heidi Fisher, a post-doctoral student ...
Breaking Biology News(10 mins):Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2When cooperation counts 2When cooperation counts 3
... SPRING HARBOR, N.Y. The appointment of James ... 1968 set off an explosive development of research at ... and wisely teams of investigators with diverse scientific interests. ... essays by the scientists involved tell the stories of ...
... on patients who have suffered a heart attack ... red yeast rice, Xuezhikang (XZK), reduced the risk ... surgery/angioplasty), cardiovascular mortality and total mortality by one-third ... double-blind study, was conducted on almost 5,000 patients, ...
... Comprehensive Cancer Center have modified a common chemotherapy drug to ... advance that will allow them to model and measure the ... The discovery, published June 8, 2008 in the early ... monitor the immune system at the whole body level ...
Cached Biology News:Watson-inspired innovation in research at Cold Spring Harbor Laboratory 2Study finds Chinese food good for your heart 2UCLA researchers develop new PET scanning probe that will allowing monitoring of the immune system 2UCLA researchers develop new PET scanning probe that will allowing monitoring of the immune system 3
(Date:7/30/2014)... 2014  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... proprietary technologies are used to discover, develop, manufacture ... bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... as Vice President and Chief Financial Officer. Tom ... information technology operations for Dyadic and will succeed ...
(Date:7/30/2014)... July 30, 2014   Epic Sciences, Inc. ... novel diagnostics to personalize and advance the treatment and ... Gregory T. Lucier as chairman of Epic,s board ... of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic,s ... its circulating rare cell analysis platform with special focus ...
(Date:7/30/2014)... , July 30, 2014  RXi Pharmaceuticals ... biotechnology company focused on discovering, developing and ... needs using RNA-targeted technologies, today announced that ... RXI-109, for the reduction of recurrence of ... has been initiated. Logo - ...
(Date:7/30/2014)... July 30, 2014 Connecticut Center for ... based in East Hartford, Conn., was awarded a Rural ... of a project that will determine the feasibility of ... north-central Connecticut. USDA Rural Development provided $53,000 for CCAT ... the second phase of the feasibility study in fiscal ...
Breaking Biology Technology:Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 2USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 3
... China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China,Clean Energy Inc. ... today announced that, as of November 10, 2008 ... decided to resume biodiesel production at its,existing plant ... material prices, thus,allowing the Company to enjoy sufficient ...
... Cord Blood,America, Inc. (OTC Bulletin Board: CBAI), the ... ) focused on,bringing the life saving potential of ... that the stem cell industry is surging with ... his executive,authority to reverse current policies barring certain ...
... , - Revenues Expected to be up 26%, ... Site Limited ("The Binding Site" or the "Company"), a,privately-owned ... the year ended 30th September 2008. The full audited,results ... are expected to be GBP38.9 million, representing sales growth,of ...
Cached Biology Technology:China Clean Energy Resumes Biodiesel Production After Temporary Halt 2China Clean Energy Resumes Biodiesel Production After Temporary Halt 3Cord Blood America Salutes President-Elect Obama's Promise to Lift Restrictions on Stem Cell Research 2The Binding Site Announces Trading Update for Year Ended September 30th 2008 2The Binding Site Announces Trading Update for Year Ended September 30th 2008 3
SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*...
... Reticulocyte Lysate contains the cellular components necessary ... initiation, elongation and termination factors) but has ... Lysate is used primarily for the isolation ... source of endogenous globin mRNA. Untreated Lysate ...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Coverslips for Microarrays, 1. *Category: MICROARRAY ACCESSORIES....
Biology Products: